[HTML][HTML] Research progress of natural products for the treatment of ischemic stroke

J Li, T Zhao, H Qiao, Y Li, M Xia, X Wang… - Journal of Integrative …, 2022 - imrpress.com
Stroke is a leading cause of death and disability world-widely. The incidence rate of stroke
has been increasing due to the aging population and lifestyle changes. At present, the only …

mTOR pathway–a potential therapeutic target in stroke

K Melanis, MI Stefanou… - Therapeutic …, 2023 - journals.sagepub.com
Stroke is ranked as the second leading cause of death worldwide and a major cause of long-
term disability. A potential therapeutic target that could offer favorable outcomes in stroke is …

Can a therapeutic strategy for hypotension improve cerebral perfusion and oxygenation in an experimental model of hemorrhagic shock and severe traumatic brain …

APCC Balzi, DA Otsuki, L Andrade, W Paiva… - Neurocritical Care, 2023 - Springer
Background Restoration of brain tissue perfusion is a determining factor in the neurological
evolution of patients with traumatic brain injury (TBI) and hemorrhagic shock (HS). In a …

Platelet membrane-encapsulated Ginkgolide B Biomimetic nanoparticles for the treatment of ischemic stroke

JW Cui, HC Feng, C Xu, DY Jiang… - ACS Applied Nano …, 2023 - ACS Publications
Stroke is a highly lethal and disabling disease of the central nervous system exacerbated by
oxidative stress, inflammation, and ferroptosis. However, the blood–brain barrier makes it …

[HTML][HTML] Age-related alterations in Immune function and inflammation: focus on ischemic stroke

Q Chen, M Wu, Q Tang, P Yan, L Zhu - Aging and Disease, 2024 - ncbi.nlm.nih.gov
The aging of the global population poses significant scientific challenges. Moreover, the
biological process of aging is the most significant risk factor for most chronic illnesses; …

Role of neutrophil-lymphocyte ratio in the prognosis of acute ischaemic stroke after reperfusion therapy: A systematic review and meta-analysis

D Sharma, KJ Spring… - Journal of Central …, 2022 - journals.sagepub.com
Background Inflammation may mediate response to acute reperfusion therapy (RT) in acute
cerebral ischaemia. Neutrophil-lymphocyte ratio (NLR), an inflammatory biomarker, may …

An updated review of mitochondrial transplantation as a potential therapeutic strategy against cerebral ischemia and cerebral ischemia/reperfusion injury

H Huang, TT Oo, N Apaijai, N Chattipakorn… - Molecular …, 2023 - Springer
Regardless of the progress made in the pathogenesis of ischemic stroke, it remains a
leading cause of adult disability and death. To date, the most effective treatment for ischemic …

Human Glial Cells as Innovative Targets for the Therapy of Central Nervous System Pathologies

G Magni, B Riboldi, S Ceruti - Cells, 2024 - mdpi.com
In vitro and preclinical in vivo research in the last 35 years has clearly highlighted the crucial
physiopathological role of glial cells, namely astrocytes/microglia/oligodendrocytes and …

Depletion of iNOS-positive inflammatory cells decelerates neuronal degeneration and alleviates cerebral ischemic damage by suppressing the inflammatory response

T Li, T Xu, J Zhao, H Gao, W Xie - Free Radical Biology and Medicine, 2022 - Elsevier
Ischemic stroke leads to neuronal damage and severe inflammation that activate iNOS
expression in different cell types, especially inflammatory cells in the brain. It is shown that …

Long noncoding RNA SNHG14 promotes ischemic brain injury via regulating miR-199b/AQP4 axis

G Zhang, T Li, X Chang, J Xing - Neurochemical research, 2021 - Springer
Background Ischemic stroke is the leading cause of disability worldwide. Long noncoding
RNAs (lncRNAs) play important roles in the pathogenesis of cerebral ischemia. This study …